$306.91 +3.45 (%) Allergan PLC - NYSE

Jul. 1, 2015 | 04:00 PM

Partner Headlines

  1. Top Takeaways From BMO's Specialty Pharma Day

    Benzinga | Jul. 1, 2015 | 13:13PM EST
  2. Leerink Downgrades Kythera, Says Allergan Deal Likely To Close At $75 Mark

    Benzinga | Jun. 29, 2015 | 07:46AM EST
  3. Acquisition in the Health Care Industry Increased Volatility

    GuruFocus | Jun. 27, 2015 | 20:15PM EST
  4. Zoetis Loses All Of Thursday's Spike On Valeant Buzz

    IBD | Jun. 26, 2015 | 16:45PM EST
  5. Horizon Pharma Seen In Deal-Making Mode

    IBD | Jun. 26, 2015 | 12:27PM EST
  6. Benzinga's M&A Chatter for Thursday June 25, 2015

    Benzinga | Jun. 25, 2015 | 18:16PM EST
  7. Julian Robertson Adds 16 New Stakes to Portfolio

    GuruFocus | Jun. 23, 2015 | 18:39PM EST
  8. CVC

    IBD | Jun. 22, 2015 | 18:39PM EST
  9. Benzinga's M&A Chatter for Wednesday June 18, 2015

    Benzinga | Jun. 18, 2015 | 20:06PM EST
  10. Benzinga's M&A Chatter for Thursday June 18, 2015

    Benzinga | Jun. 18, 2015 | 20:06PM EST
  11. Allergan Adds To Aesthetics

    IBD | Jun. 17, 2015 | 18:51PM EST
  12. Benzinga's M&A Chatter for Wednesday June 17, 2015

    Benzinga | Jun. 17, 2015 | 18:17PM EST
  13. Mid-Afternoon Market Update: DavidsTea Falls After Q1 Results; Synergy Pharmaceuticals Shares Spike Higher

    Benzinga | Jun. 17, 2015 | 14:55PM EST
  14. How High Can Eagle Pharmaceuticals Fly On Teva Deal?

    IBD | Jun. 17, 2015 | 13:37PM EST
  15. Mid-Day Market Update: Kythera Biopharmaceuticals Jumps On Acquisition News; La-Z-Boy Shares Slide

    Benzinga | Jun. 17, 2015 | 13:03PM EST
  16. Mid-Morning Market Update: Markets Rise; Allergan To Acquire Kythera Biopharmaceuticals For $2.1B

    Benzinga | Jun. 17, 2015 | 10:30AM EST
  17. Allergan Expands Aesthetics Line With Kythera Buyout

    IBD | Jun. 17, 2015 | 10:29AM EST
  18. Benzinga's Volume Movers

    Benzinga | Jun. 17, 2015 | 10:20AM EST
  19. Morning Market Gainers

    Benzinga | Jun. 17, 2015 | 09:42AM EST
  20. Stock Futures Trim Early Gains; Kythera, Qihoo Rise, FedEx Slips

    IBD | Jun. 17, 2015 | 09:10AM EST
  21. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 17, 2015 | 08:09AM EST
  22. US Stock Futures Up; All Eyes On Fed Decision

    Benzinga | Jun. 17, 2015 | 07:29AM EST
  23. UPDATE: Allergan to Acquire KYTHERA Biopharmaceuticals

    Benzinga | Jun. 17, 2015 | 07:02AM EST
  24. Actavis Stock - A Must Have For Long-Term Investors

    GuruFocus | May. 27, 2015 | 11:34AM EST
  25. Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter

    Benzinga | May. 18, 2015 | 13:38PM EST
  26. John Paulson Continues To Bet On Health Care And TV

    Benzinga | May. 17, 2015 | 10:49AM EST
  27. Bill Ackman's Latest Moves In Health Care & Some Other Positions From Q1

    Benzinga | May. 16, 2015 | 09:54AM EST
  28. The Latest Stock Picks From Cliff Asness, AQR Capital's 13F

    Benzinga | May. 15, 2015 | 15:46PM EST
  29. Top Funds Buying Rackspace, Allergan ogen Idec, Apple

    IBD | Mar. 3, 2015 | 18:50PM EST
  30. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  31. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  32. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  33. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  34. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus | Feb. 24, 2015 | 12:09PM EST
  35. Tax System Gives Edge To Foreign Buys Of U.S. Firms

    IBD | Feb. 23, 2015 | 18:51PM EST
  36. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  37. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  38. Weekly 52-Week Highs Highlight: DG, AGN, ADSK, AVGO, PCYC

    GuruFocus | Feb. 22, 2015 | 18:55PM EST
  39. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD | Feb. 22, 2015 | 17:46PM EST
  40. John Paulson's Top Buys

    GuruFocus | Feb. 21, 2015 | 22:52PM EST
  41. A Look at Larry Robbins and His Latest Portfolio Update

    GuruFocus | Feb. 20, 2015 | 15:16PM EST
  42. Medical Stocks Rise; Valeant Said To Be Near Buy Of Salix

    IBD | Feb. 20, 2015 | 11:54AM EST
  43. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD | Feb. 20, 2015 | 11:42AM EST
  44. Actavis Tops, Changing Name

    IBD | Feb. 18, 2015 | 18:22PM EST
  45. A Look At Dan Loeb's Diversified 13F

    Benzinga | Feb. 18, 2015 | 18:04PM EST
  46. Paulson & Company's Q4 Moves: Healthcare And Beyond

    Benzinga | Feb. 18, 2015 | 16:12PM EST
  47. Actavis Tops Views, Announces Name Change To Allergan

    IBD | Feb. 18, 2015 | 11:24AM EST
  48. Ackman's Pershing Square Scaled Back Allergan, Added To Platform Specialty Products In Q4

    Benzinga | Feb. 17, 2015 | 18:17PM EST
  49. Actavis Leads IBD 50 Stocks With Earnings This Week

    IBD | Feb. 14, 2015 | 08:02AM EST
  50. An Inside Scoop on Investing Insight from Pershing's Ackman

    FoxBusiness | Feb. 13, 2015 | 19:06PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!